Author:
Sawarkar Gaurav,Desai Priti,Sawarkar Punam
Abstract
Introduction: Sushruta stated that Sira Vedha (phlebotomy) at Right Elbow Joint was used as a cure for Liver Diseases. Modern science is likewise on the same page as phlebotomy treatment for some liver illnesses, although the specific location for phlebotomy has not been specified. Similarly, there is diversity in the amount of blood extracted and the time length, with each research study recommending a different amount to be removed and the gap between two sessions. Both of the previously listed things are mentioned in the context of Ayurveda. Nonetheless, due to a lack of clinical proof, it cannot be practiced reliably in normal exercise. As a result, clinical proof for liver illnesses is required to confirm Sushruta’s theory. Methodology: 111 eligible patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Grade I/II were randomly assigned to the control (group A) or trial (group B) groups in the pilot research (group B). After obtaining written informed permission, blood samples from each patient were collected for LFT and lipid profile testing. The patients in Group A were then just counseled to make dietary changes. Group B patients underwent dietary changes as well as Sira Vedha (phlebotomy) with 65 cc blood three times in 15 days. Checked hemoglobin before each phlebotomy for safety considerations before discontinuing the patient. The blood sample was taken before enrollment in the study and after the final follow-up, which was on the 60th day. Results: The serum results from the first and last follow-ups were compared. This study found that group B considerably improved in liver enzymes and lipid profile (P<0.050) when compared to group A. As a result, we may infer that phlebotomy can enhance liver enzymes and lipid profiles in NAFLD patients.
Publisher
Informatics Publishing Limited
Reference55 articles.
1. Organisation mondiale de la Santé. Manuel d’investigation des flambées épidémiques d’étiologie chimique présumée : orientation pour l’investigation et la régulation [Internet]. Genève: Organisation mondiale de la Santé; 2022 [cited 2022 May 12].
2. Khodadoostan M, Zamanidoost M, Shavakhi A, Sanei H, Shahbazi M, Ahmadian M. Effects of phlebotomy on liver enzymes and histology of patients with nonalcoholic fatty liver disease. Adv Biomed Res. 2017; 6:12. https://doi. org/10.4103/2277-9175.200787 PMid:28299304 PMCid: PMC5343605
3. Lainé F, Ruivard M, Loustaud-Ratti V, Bonnet F, Calès P, Bardou-Jacquet E, et al. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients. Hepatol Baltim Md. 2017; 65(2):465–74. https://doi.org/10.1002/ hep.28856 PMid:27685251
4. Rawal M, Chudasma KM, Vyas RV, Parmar BP. Effect of vasantic vaman and other panchakarma procedures on disorders of various systems. Ayu. 2010; 31(3):319–24. https://doi.org/10.4103/0974-8520.77160 PMid:22131733 PMCid:PMC3221065
5. Raval HN, Thakar AB. Role of raktamokshana by jalaukavacharana and siravedhana in the management of vicharchika (eczema). Ayu. 2012; 33(1):68–72. https://doi. org/10.4103/0974-8520.100314 PMid:23049187 PMCid: PMC3456867